{"DataElement":{"publicId":"5291151","version":"1","preferredName":"BCR/ABL1 Fusion Gene Translocation Breakpoint Present Specify Text","preferredDefinition":"The free-text field to describe the BCR / ABL1 fusion gene breakpoint that was present.","longName":"5291136v1.0:2799057v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5291136","version":"1","preferredName":"BCR/ABL1 Fusion Gene Translocation Breakpoint Present","preferredDefinition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia._The point on a chromosome where the normal DNA sequence is juxtaposed with DNA from another chromosome.  Usually expressed as a band number designation (eg. t(9;22) (q34;q11) Philadelphia Chromosome)_Being or existing in a specified place or at the specified time.","longName":"5484975v1.0:2233878v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5484975","version":"1","preferredName":"BCR/ABL1 Fusion Gene Translocation Breakpoint","preferredDefinition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.:The point on a chromosome where the normal DNA sequence is juxtaposed with DNA from another chromosome.  Usually expressed as a band number designation (eg. t(9;22) (q34;q11) Philadelphia Chromosome)","longName":"C94600:C13660","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR/ABL1 Fusion Gene","conceptCode":"C94600","definition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Translocation Breakpoint","conceptCode":"C13660","definition":"The point on a chromosome where the normal DNA sequence is juxtaposed with DNA from another chromosome.  Usually expressed as a band number designation (eg. t(9;22) (q34;q11) Philadelphia Chromosome)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D6C2975-15BC-30A8-E053-F662850ADD77","latestVersionIndicator":"Yes","beginDate":"2016-09-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-09-26","modifiedBy":"ONEDATA","dateModified":"2016-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435027","version":"1","preferredName":"Gene","preferredDefinition":"A functional unit of heredity which occupies a specific position (locus) on a particular chromosome, is capable of reproducing itself exactly at each cell division, and directs the formation of a protein or other product. The gene as a functional unit consists of a discrete segment of a giant DNA molecule containing the purine (adenine and guanine) and pyrimidine (cytosine and thymine) bases in the ordered and correct sequence that encodes a specific functional product (i.e., a protein or RNA molecule).","longName":"C16612","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB05-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"353EE0ED-AB35-FCAF-E050-BB89AD43034A","latestVersionIndicator":"Yes","beginDate":"2016-06-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-06-14","modifiedBy":"NYCHM","dateModified":"2017-02-02","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2799057","version":"1","preferredName":"Specify Text","preferredDefinition":"Be specific about something; define clearly._Text; the words of something written.","longName":"SPC_TXT","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2799056","version":"1","preferredName":"Specify Text","preferredDefinition":"Specify; be specific about something; define clearly.:Text; the words of something written.","longName":"C25685:C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B6FE321-D89B-66BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-11","modifiedBy":"ONEDATA","dateModified":"2008-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B6FE321-D8AC-66BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-11","modifiedBy":"MALUMK","dateModified":"2021-01-19","changeDescription":"03/17/10-Added CSI for F2000-CJL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CMLF_DABR_BCR_ABL_breakpt_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLF_PHPI_BCR_ABL_breakpt_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLP_LSDX_BCR_ABL_breakpt_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLP_LSLE_BCR_ABL_breakpt_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLP_LTHM_BCR_ABL_breakpt_spec","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Specify the BCR / ABL1 fusion","type":"Preferred Question Text","description":"Specify the BCR / ABL1 fusion gene breakpoint that was present:","url":null,"context":"NHLBI"},{"name":"Specify BCR / ABL breakpoint","type":"Alternate Question Text","description":"Specify BCR / ABL breakpoint","url":null,"context":"NHLBI"},{"name":"Specify other breakpoint:","type":"Application Standard Question Text","description":"Specify other breakpoint:","url":null,"context":"NHLBI"},{"name":"Specify other breakpoint:","type":"Alternate Question Text","description":"Specify other breakpoint:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"353F3BD7-9386-A8EF-E050-BB89AD431F93","latestVersionIndicator":"Yes","beginDate":"2016-06-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-06-14","modifiedBy":"NYCHM","dateModified":"2017-02-02","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}